Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten H Ecke

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Urologic Oncology|February 10, 2021
Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusionThorsten H Ecke, Dagmar Schwaiger, Gregorij Nesterov, et al.
European Urology Open Science|August 2, 2021
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case ReportSarah Weiß, Steffen Hallmann, Stefan Koch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Anticancer Research|October 26, 2022
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat<sup>®</sup>, NMP22<sup>®</sup> BladderChek<sup>®</sup> and UBC<sup>®</sup> <i>Rapid</i> Test)Thorsten H Ecke, Mikolaj Scislowski, Nazia Hassan, et al.
Scientific Reports|December 23, 2024
Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancerAnja Rabien, Dezhi Rong, Silke Rabenhorst, et al.
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
International Journal of Molecular Sciences|November 12, 2016
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate CancerThorsten H Ecke, Hui-Juan Huang-Tiel, Klaus Golka, et al.
Urologic Oncology|February 23, 2013
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancerMatthew D Galsky, Susan Krege, Chia-Chi Lin, et al.
Clinical Genitourinary Cancer|May 16, 2013
The impact of gender on outcomes in patients with metastatic urothelial carcinomaLindsay Haines, Aristotle Bamias, Susan Krege, et al.
Advances in Therapy|February 25, 2017
Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3Holger Gerullis, Dimitri Barski, Evangelos Georgas, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Urologic Oncology|February 10, 2021
Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusionThorsten H Ecke, Dagmar Schwaiger, Gregorij Nesterov, et al.
European Urology Open Science|August 2, 2021
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case ReportSarah Weiß, Steffen Hallmann, Stefan Koch, et al.
Anticancer Research|July 2, 2010
TP53 gene mutations in prostate cancer progressionThorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, et al.
Anticancer Research|October 26, 2022
Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat<sup>®</sup>, NMP22<sup>®</sup> BladderChek<sup>®</sup> and UBC<sup>®</sup> <i>Rapid</i> Test)Thorsten H Ecke, Mikolaj Scislowski, Nazia Hassan, et al.
Scientific Reports|December 23, 2024
Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancerAnja Rabien, Dezhi Rong, Silke Rabenhorst, et al.
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
International Journal of Molecular Sciences|November 12, 2016
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate CancerThorsten H Ecke, Hui-Juan Huang-Tiel, Klaus Golka, et al.
Urologic Oncology|February 23, 2013
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancerMatthew D Galsky, Susan Krege, Chia-Chi Lin, et al.
Clinical Genitourinary Cancer|May 16, 2013
The impact of gender on outcomes in patients with metastatic urothelial carcinomaLindsay Haines, Aristotle Bamias, Susan Krege, et al.
Advances in Therapy|February 25, 2017
Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3Holger Gerullis, Dimitri Barski, Evangelos Georgas, et al.
Pageof 7